GBS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.27%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

GBS Insider Trading History Chart

GBS Share Price & Price History

^$1.30

▲ +0.03 (2.36%)

As of 12/20/2024 01:00 AM ET

Days: 30 | 90 | 365

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.

GBS Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/22/2022	Spiro Kevin Sakiris	CFO	Buy	5,000	$0.65	$3,250.00	50,228
6/17/2022	Spiro Kevin Sakiris	Insider	Buy	15,970	$0.61	$9,741.70	45,228
2/16/2022	Science Biosensor Diagnos Life	Major Shareholder	Sell	100,000	$0.63	$63,000.00
2/14/2022	Science Biosensor Diagnos Life	Major Shareholder	Sell	100,000	$0.70	$70,000.00
2/10/2022	Science Biosensor Diagnos Life	Major Shareholder	Sell	100,000	$0.84	$84,000.00
2/8/2022	Science Biosensor Diagnos Life	Major Shareholder	Sell	100,000	$0.89	$89,000.00
2/2/2022	Science Biosensor Diagnos Life	Major Shareholder	Sell	100,000	$0.92	$92,000.00
1/31/2022	Science Biosensor Diagnos Life	Major Shareholder	Sell	100,000	$0.90	$90,000.00
1/28/2022	Science Biosensor Diagnos Life	Major Shareholder	Sell	100,000	$0.92	$92,000.00

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

SEC Filings (Institutional Ownership Changes) for GBS (NYSE:GBS)

2.79% of GBS stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

GBS Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/9/2021	BlackRock Inc.	21,812	$55K	0.0%	+4,119.0%	0.147%
9/17/2021	Virtu Financial LLC	24,897	$98K	0.0%	N/A	0.201%
8/17/2021	Bridgeway Capital Management LLC	118,000	$0.47M	0.0%	+555.6%	0.953%
8/13/2021	Anson Funds Management LP	571,401	$2.25M	0.2%	N/A	4.615%
8/13/2021	Geode Capital Management LLC	10,938	$43K	0.0%	N/A	0.088%
8/13/2021	Vanguard Group Inc.	18,854	$74K	0.0%	N/A	0.152%
8/6/2021	WealthShield Partners LLC	49,147	$0.19M	0.0%	N/A	0.397%
5/21/2021	Citadel Advisors LLC	27,939	$0.16M	0.0%	N/A	0.226%
5/18/2021	Citadel Advisors LLC	27,939	$0.16M	0.0%	N/A	0.235%
2/17/2021	Jane Street Group LLC	16,182	$0.12M	0.0%	N/A	0.137%

Data available starting January 2016

GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Today's Range

Now: $1.30

$1.24

$1.36

50 Day Range

MA: $1.51

$0.47

$1.94

52 Week Range

Now: $1.30

$0.36

$2.89

Volume

155,796 shs

Average Volume

955,325 shs

Market Capitalization

$19.36 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad